118 related articles for article (PubMed ID: 28088627)
21. Knockdown of telomeric repeat binding factor 2 enhances tumor radiosensitivity regardless of telomerase status.
Yang X; Li Z; Yang L; Lei H; Yu H; Liao Z; Zhou F; Xie C; Zhou Y
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1545-52. PubMed ID: 25609072
[TBL] [Abstract][Full Text] [Related]
22. The differential effects of metronomic gemcitabine and antiangiogenic treatment in patient-derived xenografts of pancreatic cancer: treatment effects on metabolism, vascular function, cell proliferation, and tumor growth.
Yapp DT; Wong MQ; Kyle AH; Valdez SM; Tso J; Yung A; Kozlowski P; Owen DA; Buczkowski AK; Chung SW; Scudamore CH; Minchinton AI; Ng SS
Angiogenesis; 2016 Apr; 19(2):229-44. PubMed ID: 26961182
[TBL] [Abstract][Full Text] [Related]
23. Discovery of a selective TRF2 inhibitor FKB04 induced telomere shortening and senescence in liver cancer cells.
Qiu YD; Yan Q; Wang Y; Ye YF; Wang Y; Wang MY; Wang PP; Zhang SY; Wang DL; Yan H; Ruan J; Zhao YJ; Huang LH; Cho N; Wang K; Zheng XH; Liu ZG
Acta Pharmacol Sin; 2024 Jun; 45(6):1276-1286. PubMed ID: 38438580
[TBL] [Abstract][Full Text] [Related]
24. Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers.
Yamada M; Tsuji N; Nakamura M; Moriai R; Kobayashi D; Yagihashi A; Watanabe N
Anticancer Res; 2002; 22(6A):3303-7. PubMed ID: 12530079
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics and Pharmacodynamics-Based Mathematical Modeling Identifies an Optimal Protocol for Metronomic Chemotherapy.
Ciccolini J; Barbolosi D; Meille C; Lombard A; Serdjebi C; Giacometti S; Padovani L; Pasquier E; André N
Cancer Res; 2017 Sep; 77(17):4723-4733. PubMed ID: 28655786
[TBL] [Abstract][Full Text] [Related]
26. DNA-PKcs-interacting protein KIP binding to TRF2 is required for the maintenance of functional telomeres.
Khadka P; Lee JH; Baek SH; Oh SY; Chung IK
Biochem J; 2014 Oct; 463(1):19-30. PubMed ID: 25012820
[TBL] [Abstract][Full Text] [Related]
27. Sp1 upregulates expression of TRF2 and TRF2 inhibition reduces tumorigenesis in human colorectal carcinoma cells.
Dong W; Shen R; Wang Q; Gao Y; Qi X; Jiang H; Yao J; Lin X; Wu Y; Wang L
Cancer Biol Ther; 2009 Nov; 8(22):2166-74. PubMed ID: 19783902
[TBL] [Abstract][Full Text] [Related]
28. TRF2 Protein Interacts with Core Histones to Stabilize Chromosome Ends.
Konishi A; Izumi T; Shimizu S
J Biol Chem; 2016 Sep; 291(39):20798-810. PubMed ID: 27514743
[TBL] [Abstract][Full Text] [Related]
29. Metronomic chemotherapy following the maximum tolerated dose is an effective anti-tumour therapy affecting angiogenesis, tumour dissemination and cancer stem cells.
Vives M; Ginestà MM; Gracova K; Graupera M; Casanovas O; Capellà G; Serrano T; Laquente B; Viñals F
Int J Cancer; 2013 Nov; 133(10):2464-72. PubMed ID: 23649709
[TBL] [Abstract][Full Text] [Related]
30. Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells.
Spyridopoulos I; Haendeler J; Urbich C; Brummendorf TH; Oh H; Schneider MD; Zeiher AM; Dimmeler S
Circulation; 2004 Nov; 110(19):3136-42. PubMed ID: 15520325
[TBL] [Abstract][Full Text] [Related]
31. Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells.
Yu Y; Wang J; Xia N; Li B; Jiang X
Oncol Rep; 2015 Apr; 33(4):1683-90. PubMed ID: 25633045
[TBL] [Abstract][Full Text] [Related]
32. Control of human telomere length by TRF1 and TRF2.
Smogorzewska A; van Steensel B; Bianchi A; Oelmann S; Schaefer MR; Schnapp G; de Lange T
Mol Cell Biol; 2000 Mar; 20(5):1659-68. PubMed ID: 10669743
[TBL] [Abstract][Full Text] [Related]
33. Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy.
Grisanti S; Cosentini D; Laganà M; Morandi A; Lazzari B; Ferrari L; Volta AD; Ambrosini R; Ferrari VD; Sigala S; Berruti A
Front Endocrinol (Lausanne); 2021; 12():624102. PubMed ID: 33716976
[TBL] [Abstract][Full Text] [Related]
34. Promotion of tumor progression induced by continuous low-dose administration of antineoplastic agent gemcitabine or gemcitabine combined with cisplatin.
Chen Y; Liu H; Zheng Q; Li H; You H; Feng Y; Feng W
Life Sci; 2022 Oct; 306():120826. PubMed ID: 35870618
[TBL] [Abstract][Full Text] [Related]
35. Telomerase abrogation dramatically accelerates TRF2-induced epithelial carcinogenesis.
Blanco R; Muñoz P; Flores JM; Klatt P; Blasco MA
Genes Dev; 2007 Jan; 21(2):206-20. PubMed ID: 17234886
[TBL] [Abstract][Full Text] [Related]
36. Essential role for the TRF2 telomere protein in adult skin homeostasis.
Martínez P; Ferrara-Romeo I; Flores JM; Blasco MA
Aging Cell; 2014 Aug; 13(4):656-68. PubMed ID: 24725274
[TBL] [Abstract][Full Text] [Related]
37. ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2.
Bluhm A; Viceconte N; Li F; Rane G; Ritz S; Wang S; Levin M; Shi Y; Kappei D; Butter F
Nucleic Acids Res; 2019 Feb; 47(4):1896-1907. PubMed ID: 30629181
[TBL] [Abstract][Full Text] [Related]
38. Telomere repeat-binding factor 2 binds extensively to extra-telomeric G-quadruplexes and regulates the epigenetic status of several gene promoters.
Mukherjee AK; Sharma S; Bagri S; Kutum R; Kumar P; Hussain A; Singh P; Saha D; Kar A; Dash D; Chowdhury S
J Biol Chem; 2019 Nov; 294(47):17709-17722. PubMed ID: 31575660
[TBL] [Abstract][Full Text] [Related]
39. Gemcitabine as a molecular targeting agent that blocks the Akt cascade in platinum-resistant ovarian cancer.
Kawaguchi H; Terai Y; Tanabe A; Sasaki H; Takai M; Fujiwara S; Ashihara K; Tanaka Y; Tanaka T; Tsunetoh S; Kanemura M; Ohmichi M
J Ovarian Res; 2014 Apr; 7():38. PubMed ID: 24713296
[TBL] [Abstract][Full Text] [Related]
40. Suppression of Ku80 correlates with radiosensitivity and telomere shortening in the U2OS telomerase-negative osteosarcoma cell line.
Hu L; Wu QQ; Wang WB; Jiang HG; Yang L; Liu Y; Yu HJ; Xie CH; Zhou YF; Zhou FX
Asian Pac J Cancer Prev; 2013; 14(2):795-9. PubMed ID: 23621240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
